IO Biotech (IOBT) is scheduled to report topline results of its pivotal Phase 3 trial of its investigational off-the-shelf therapeutic cancer vaccine, Cylembio, in combination with Merck's Keytruda as a first-line treatment for unresectable or metastatic (advanced) melanoma today. Shares are up over 35%.
The following is the list of biotech stocks making big moves in premarket trading today.
For comments and feedback contact: editorial@rttnews.com
May 01, 2026 15:54 ET Central banks dominated the economics news flow this week with almost all major ones announcing their latest policy decisions and many boosted expectations for a rate hike in June. In other news, several countries released the preliminary data for first quarter economic growth. In the U.S., comments by Fed Chair Jerome Powell were also in focus as his term ends this month.